{"id":"https://genegraph.clinicalgenome.org/r/e31a02c5-b59a-4e19-953b-4378d27487c2v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the FANCC gene with Fanconi anemia complementation group C, since the gene-disease relationship was first proposed by Gavish et al. (1992). Multiple case level studies have been performed with FA patients that have variants in the FANCC gene. Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 in the FA/BRCA DNA repair pathway. Multiple Fancc deficient mouse models have been established to show consistent phenotypes with FA patients including impaired fertility, chromosome breakage and cross linker sensitivity, and spontaneous hematologic sequelae. All of these types of evidence are consistent with a definitive relationship between the FANCC gene and Fanconi anemia complementation group C.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e31a02c5-b59a-4e19-953b-4378d27487c2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4680d59-7309-495d-9eab-d52219e1cade","type":"EvidenceLine","dc:description":"Reduced points because this is a Fancc-/-;Fancg-/- double knockout mouse model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b125eac3-576f-4011-a4b3-fa30e0ca4ff2","type":"Finding","dc:description":"Fancc -/-;Fancg -/- double-mutant mice developed spontaneous hematologic sequelae, including bone marrow failure, acute myeloid leukemia, myelodysplasia, and complex random chromosomal abnormalities, that Fancc -/- mice or Fancg -/- mice did not develop. The phenotype of the double-mutant mice was most consistent with that of human patients with Fanconi anemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20606166","rdfs:label":"Fancc-/-;Fancg-/- mice show spontaneous hematologic sequelae","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4ebd42d7-8213-43a0-99fe-bcd32fda01c5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51ac576d-5157-45dd-8a49-d13a731ea961","type":"Finding","dc:description":"Cells from mutant mice demonstrated chromosome breakage and crosslinker sensitivity. Male and female mutant mice had reduced numbers of germ cells and females had markedly impaired fertility. The colony-forming capacity of bone marrow progenitor cells was abnormal and these cells were hypersensitive to gamma-interferon.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8704201","rdfs:label":"Hematopoietic Hypersensitivity in Fancc -/- Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8bac7119-997a-4e6f-8ae5-cbc67bf5828c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d23af17e-d6a7-40fb-bf91-788589e43e35","type":"Finding","dc:description":"Spleen cells from mutant mice had dramatically increased numbers of chromosomal aberrations in response to mitomycin C (MMC) and diepoxybutane. Homozygous male and female mice also had compromised gametogenesis, leading to markedly impaired fertility, a characteristic of Fanconi anemia patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8630504","rdfs:label":"Fac mice show chromosomal instability and reduced fertility","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59b84c82-3ef2-40f4-b5ff-bd29c82241e6","type":"EvidenceLine","dc:description":"Eight FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efc4b327-0416-42b1-8412-4f246b0756c0","type":"Finding","dc:description":"Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 protein during S phase of the growth cycle and after exposure to DNA crosslinking agents. The FA/BRCA pathway is involved in the repair of DNA damage. They all cause Fanconi anaemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29376519","rdfs:label":"Eight of the FA proteins are assembled in a nuclear complex","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf4881c3-15b3-4e10-bd24-2da80433863b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ac8a15f-9062-4414-9253-91faa96e6453_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","rdfs:label":"640","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/8ac8a15f-9062-4414-9253-91faa96e6453","type":"Family","rdfs:label":"640","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ea068987-9210-423b-9bd1-fb4f22e3ac13","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","rdfs:label":"640/1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":["obo:HP_0030260","obo:HP_0005528","obo:HP_0004712","obo:HP_0000957","obo:HP_0000073"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4660628-8f6a-4cac-bd69-363f23bc22b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","allele":[{"id":"https://genegraph.clinicalgenome.org/r/50a766ee-635f-493e-bb37-6ac68e5cf1f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.165+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12051"}},{"id":"https://genegraph.clinicalgenome.org/r/de061226-8a18-4982-a491-670a2b92e270","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"FANCC, 250-BP DEL","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12052"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Fanconi anemia","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000073","obo:HP_0005528","obo:HP_0000957","obo:HP_0004712","obo:HP_0030260"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ea068987-9210-423b-9bd1-fb4f22e3ac13"}},{"id":"https://genegraph.clinicalgenome.org/r/f3476de7-3173-49ad-9859-6a927c51888a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","rdfs:label":"pedigrees 526 and 1159","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/f3476de7-3173-49ad-9859-6a927c51888a","type":"Family","rdfs:label":"pedigrees 526 and 1159","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/93d4653f-0b1e-4c2e-90f6-d3cd17b36f61","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","rdfs:label":"526/1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":["obo:HP_0005528","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e8f37b62-2ffd-45f7-a59e-6bf481c1d041_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20869034","allele":{"id":"https://genegraph.clinicalgenome.org/r/50a766ee-635f-493e-bb37-6ac68e5cf1f9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Fanconi anemia","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000957","obo:HP_0005528"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/93d4653f-0b1e-4c2e-90f6-d3cd17b36f61"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e4660628-8f6a-4cac-bd69-363f23bc22b9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygous for the intron 2 mutation and a 250-bp deletion, resulting in the skipping of exons 2 and 3.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea068987-9210-423b-9bd1-fb4f22e3ac13"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ba8176e5-bd11-4e3f-8d47-d11f87daec9a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Two mutations, one in exon 1 (322delG) and the other in exon 4 (IVS4+4A-T), account for 90% of known FAC mutations. Both are two star variants in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e1fda2e-08bb-4058-b5cc-5957c65a63e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8639804","rdfs:label":"VU239","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba8176e5-bd11-4e3f-8d47-d11f87daec9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8639804","allele":[{"id":"https://genegraph.clinicalgenome.org/r/11690ccc-8000-4bdc-94e7-35d74a77f518","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.456+4A>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12045"}},{"id":"https://genegraph.clinicalgenome.org/r/92024bdc-e3c0-43f4-b066-5f3a7eefd34a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.67delG (p.Asp23Ilefs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12049"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/257cc528-b1ea-47eb-9f98-3677f3f58527_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for a gln13-to-ter (Q13X) mutation in exon 1 of the FACC gene and an R548X mutation in exon 14. Both are two star variants in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd3a6c11-e16c-4bf5-a2ad-63047050a71b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8103176","rdfs:label":"affected fetus","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mismatch analysis with chemical cleavage with osmium tetroxide and hydroxylamine","firstTestingMethod":"Other","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/257cc528-b1ea-47eb-9f98-3677f3f58527_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8103176","allele":[{"id":"https://genegraph.clinicalgenome.org/r/34bd0e4c-e26f-40cb-b8f5-3f428b2c5598","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.1642C>T (p.Arg548Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12047"}},{"id":"https://genegraph.clinicalgenome.org/r/a3c7c68b-8885-4d19-873b-ea538f71a4bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.37C>T (p.Gln13Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12046"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f2a4df94-3c5e-4a7e-9b1b-09df7c0ebfd2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The insertion caused a frameshift that was expected to give rise to a truncated protein of 526 amino acids, which is shorter than the protein resulting from premature termination caused by the R548X mutation, and therefore presumed to be inactive. 322delG is a two star variant in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7ad4790-f7a0-4880-b07c-99598de9ecbb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8829660","rdfs:label":"FA patient (coded ST)","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":true,"previousTestingDescription":"This is the same patient as described in Arwert et al. (1989)","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f2a4df94-3c5e-4a7e-9b1b-09df7c0ebfd2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8829660","allele":[{"id":"https://genegraph.clinicalgenome.org/r/92024bdc-e3c0-43f4-b066-5f3a7eefd34a"},{"id":"https://genegraph.clinicalgenome.org/r/f86127f9-27d5-460b-863e-27644ef1f20b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000136.2(FANCC):c.1555dupA (p.Thr519Asnfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12048"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e8f37b62-2ffd-45f7-a59e-6bf481c1d041_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous G-to-T transversion in intron 2 of the FANCC gene (165+1G-T), changing a highly conserved GT dinucleotide to TT at the 5-prime splice site. Increase points because 7 affected members of 2 unrelated but consanguineous families of Arabian ancestry were studied.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93d4653f-0b1e-4c2e-90f6-d3cd17b36f61"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":352,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/HVRzrO0NlxY","type":"GeneValidityProposition","disease":"obo:MONDO_0009213","gene":"hgnc:3584","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cf4881c3-15b3-4e10-bd24-2da80433863b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}